Zuyderland Medisch Centrum Stichting — Clinical Trial Site

133 Registered trials

55 Currently recruiting

Organisation

Zuyderland Medisch Centrum Stichting

Location

Heerlen, Netherlands

Identifier

ORG-100023231

Address

Henri Dunantstraat 5, 6419 PC, Netherlands

Departments

#3356:Cardiology
#3719: Cardiology
#6001:Neurology
3024: Neurology
3719: Cardiology
5004:Pulmonology
7003: Rheumatology
Academisch MS Centrum Zuyderland
Atrium MC loc. Heerlen, dept. Internal medicine
Cardiology
Cardiology department
Dep of Cardiology
Department of Neurology
Department of Oncology
Department of orthopedic surgery
Department of pulmonology
Department of Respiratory Medicine
Department of Surgery
Dermatology
Endocrinologie
Gastroenterology
Gastroenterology, Geriatrics & Internal and Intensive Medicine
Gynaecology
Hematologie
Hematology
ICU
Internal Medicine
Internal Medicine - Hematology
Internal Medicine / Oncology
Internal Medicine and Oncology
Internal Medicine, Medical Oncology
Internal Medicine/oncology
interne geneeskunde
Longgeneeskunde
Longoncologie
Lung disease
MDL
Medical oncology
Medische Oncologie
N/A
Neurologie
Neurology
Neurosurgery
Not applicable
Obstetrics & Gynecology
Oncology
Orthopedic surgery
Pulmonary diseases
Pulmonary medicine
Pulmonary Science
Pulmonology
R&D Longziekte
R&D Longziekten
Reproductive medicine and gynecology
Rhematology
Rheumatology
Stichting Zuyderland Medisch Centrum
Surgery
urology
Zuyderland Medisch Centrum
Zuyderland Medisch Centrum( #1)
Zuyderland ziekenhuis
Zuyderland ziekenhuis_LOC#1

Clinical trials at this site (133)

Search interface

A Study to Learn About the Study Medicine Called PF-07248144 in Combination with Fulvestrant in People with HR-positive, HER2-negative Advan… Recruiting

2025-520566-22-00 Hormone Receptor-Positive, HER2-Negative Advanced/Metas 5 2025-11-10
A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn’s Disease (CD) Recruiting

2024-518914-18-00 Moderate to Severely Active Ulcerative Colitis & Modera 4 2025-08-27
Continuing ovulation induction with letrozole versus switching to gonadotropins in women with polycystic ovary syndrome (MOVIN-II study) Recruiting

2024-519354-36-00 Polycystic ovary syndrome (PCOS) 6 2025-08-01
Study of Sacituzumab Govitecan Versus Standard of Care in Participants with Previously Treated Extensive Stage Small Cell Lung Cancer Recruiting

2024-515884-69-00 Extensive Stage Small Cell Lung Cancer (ES-SCLC) 5 2025-07-16
A clinical study of sacituzumab tirumotecan with or without pembrolizumab in people with breast cancer (MK-2870-011) Recruiting

2024-516834-36-00 Locally recurrent unresectable or metastatic TNBC with 5 2025-07-08
A Study of Nivolumab + Relatlimab Fixed-dose Combination with Chemotherapy Versus Pembrolizumab with Chemotherapy in Participants with Non-s… Recruiting

2024-513682-40-01 Non-squamous (NSQ), Stage IV or Recurrent Non-small Cel 5 2025-07-04
(PLASTIC-3) [18F]FAPI-PET/CT and Laparoscopy in STagIng advanced gastric Cancer – a multicenter prospective study Recruiting

2024-513255-32-00 Advanced gastric cancer 10 2025-07-03
A research study comparing CDR132L with placebo on the structure and function of the heart in people with heart failure with reduced/mildly … Recruiting

2024-515797-27-00 Heart Failure with Reduced/Mildly Reducede Ejection Fra 4 2025-06-25
A phase 3 multicenter, randomised, prospective, open-label trial of fixed-duration (12 cycles) venetoclax/ obinutuzumab vs. fixed-duration (… Recruiting

2023-510294-34-00 small lymphocytic lymphoma (SLL) 5 2025-06-12
StAtins in Frail oldEr patients with ischemic Stroke or Transient ischemic attack – The Randomized Controlled Trial Recruiting

2024-517343-31-00 Ischemic stroke and transient ischemic attack 6 2025-04-11
Study to Evaluate Adverse Events, Optimal Dose, and Change in Disease Activity, With Livmoniplimab in Combination With Budigalimab Plus Chem… Recruiting

2023-505773-32-00 Untreated Metastatic Non-Squamous Non-Small Cell Lung C 10 2025-03-25
Semaglutide 2.4mg for low responders after bariatric surgery Recruiting

2022-502164-20-01 obesity 6 2025-03-11
Laparoscopic Antibiotic Lavage to Prevent intra-abdominal Abscess formation in Complicated Appendicitis (ALPACA) Recruiting

2024-514850-59-00 Appendicitis 5 2025-02-24
Safe Stop Trial Melanoma Recruiting

2024-516937-10-01 Melanoma 5 2024-12-18
Stopping or continuing blood thinners after stroke at young age without a known cause: STOP trial Recruiting

2024-513092-40-00 Stroke 6 2024-12-05
The PREDMETH trial: Effectiveness of methotrexate versus prednisone as first-line therapy for pulmonary sarcoidosis – A randomized controlle… Recruiting

2024-514055-15-00 Pulmonary sarcoidosis 6 2024-11-19
DAROTAXEL Recruiting

2024-516939-28-00 metastatic castration-resistant prostate cancer 4 2024-10-28
DISTINCT: inDividual, targeted thrombosIS prophylaxis versus the standard ‘one size fits all’ approach in patients undergoing Total hIp or t… Recruiting

2023-510186-98-00 Venous thromboembolism 6 2024-10-23
PERi-operative Selective Decontamination of the Digestive tract to prevent severe infectious complications after Esophagectomy: a Randomized… Recruiting

2023-504144-33-01 esophageal cancer 11 2024-10-17
Tranexamic acid to prevent OpeRation in Chronic subdural Hematoma (TORCH) Recruiting

2024-514927-40-02 Chronic Subdural Hematoma 11 2024-10-01
A follow-up study to test long-term treatment with BI 1015550 in people with pulmonary fibrosis who took part in a previous study with BI 10… Recruiting

2023-507353-15-00 idiopathic pulmonary fibrosis (IPF) 5 2024-09-10
Study evaluating whether giving 177Lu-PSMA-617 to men having a spreading prostate cancer which does not respond well to the current standard… Recruiting

2022-502408-57-00 Novo metastatic hormone-sensitive prostate cancer (mHSP 5 2024-09-04
A Phase 2b Study to Evaluate the Efficacy and Safety of Oral TAK-279 in Subjects with Moderately to Severely Active Crohn’s Disease Recruiting

2023-506704-14-00 Moderately to Severely Active Crohn's Disease 4 2024-09-04
HOVON 170 DLBCL: ANTICIPATE: Prevention of ANThracycline-Induced Cardiac dysfunction by dexrazoxane In PATients with diffusE large B-cell ly… Recruiting

2023-505377-32-00 Diffuse large B-cell lymphoma (DLBCL) 5 2024-08-15